CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,995,859
- in 7 filings, $6.0M under 10b5-1 plans
Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-06 | Mottiwala Aziz Chief Commercial Officer | Sale 10b5-1 | −2,143 | $18.61 | $40K | 50,686 |
| 2023-05-17 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −8,000 | $15.90 | $127K | 1,043,106 |
| 2023-05-11 | LINK WILLIAM J PHD Director | Other disposition 10b5-1 | −215,576 | 0 | ||
| 2023-05-11 | LINK WILLIAM J PHD Director | Other acquisition 10b5-1 | +41,219 | 109,892 | ||
| 2023-05-10 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −9,000 | $16.80 | $151K | 1,051,106 |
| 2023-05-01 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −5,841 | $15.10 | $88K | 1,060,106 |
| 2023-04-28 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −4,278 | $15.13 | $65K | 1,065,947 |
| 2023-04-24 | Farrow Jeffrey S | Grant or award · Stock Option (right to buy) | +163,397 | 163,397 | ||
| 2023-04-24 | Farrow Jeffrey S | Grant or award · Restricted Stock Units | +111,525 | 111,525 | ||
| 2023-04-21 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −2,311 | $15.03 | $35K | 1,070,225 |
| 2023-04-20 | Greenstein Leonard M. Chief Financial Officer | Sale 10b5-1 | −5,000 | $14.02 | $70K | 26,785 |
| 2023-04-19 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −8,000 | $13.60 | $109K | 1,072,536 |
| 2023-03-23 | Wahl Bryan General Counsel | Sale | −371 | $12.15 | $5K | 16,402 |
| 2023-03-23 | Whitfield Dianne C. Chief Human Resources Officer | Sale | −345 | $12.15 | $4K | 11,219 |
| 2023-03-23 | Azamian Bobak R. President/CEO and Board Chair | Sale | −737 | $12.15 | $9K | 8,597 |
| 2023-03-23 | Neervannan Seshadri Chief Operating Officer | Sale | −390 | $12.15 | $5K | 54,696 |
| 2023-03-23 | Mottiwala Aziz Chief Commercial Officer | Sale | −372 | $12.15 | $5K | 52,829 |
| 2023-03-23 | Trevejo Jose M. CHIEF MEDICAL OFFICER | Sale | −465 | $12.15 | $6K | 6,107 |
| 2023-03-23 | Greenstein Leonard M. Chief Financial Officer | Sale | −346 | $12.15 | $4K | 31,785 |
| 2023-03-22 | Wahl Bryan General Counsel | Sale | −357 | $12.64 | $5K | 16,773 |
Page 20 of 24 · 469 trades